Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Ivabradine reduces heart volume among patients with cardiac insufficiency

As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.

30 Aug 2011

Chocolate for the heart - benefits revealed

A comprehensive analysis of previous studies including more than 114,000 subjects has shown that high levels of chocolate consumption are associated with a significant reduction in the risk of certain cardiovascular disorders.

30 Aug 2011

Specific inhibitor of microRNA-100 can stimulate development of new blood vessels

A specific inhibitor of the small regulatory RNA-molecule "microRNA-100" can be used to stimulate the growth of new blood vessels, if a major artery is chronically occluded.

29 Aug 2011

Philips to launch first sleep apnea mobile app at ESC 2011 congress

Royal Philips Electronics will provide clinicians from across the globe with a glimpse of future innovations designed to advance cardiac care, including the current management of cardiovascular disease (CVD) and associated cardiac conditions, during the 2011 Congress of the European Society of Cardiology (ESC), which opens today in Paris.

From Philips Healthcare 29 Aug 2011

Chocolate consumption might reduce risk of heart disease

High levels of chocolate consumption might be associated with a one third reduction in the risk of developing heart disease, finds a study published on bmj.com today.

29 Aug 2011

One in three AF patients at high risk of stroke are not being prescribed VKA therapy

New data show that, worldwide, one in three patients with atrial fibrillation (AF) who are at high risk for stroke are not being prescribed anticoagulant therapy, particularly vitamin K antagonists (VKA) – medicines known to significantly lower stroke risk in these patients.

29 Aug 2011

MitraClip treatment could benefit heart failure patients who are unresponsive to CRT

Results of an observational study presented at the European Society of Cardiology (ESC) meeting today in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy.

29 Aug 2011

Strong link between leisure-time physical activity and AF among men

A Norwegian survey carried out between 1974 and 2003 showed that there was a graded independent increase in the risk of AF with increasing levels of physical activity in a population-based study among men with ostensibly no other heart disease. In women the data were inconclusive.

29 Aug 2011

New clinical data shows positive long-term performance of Medtronic's CoreValve system

New clinical data presented today at the European Society of Cardiology Congress 2011 demonstrate positive long-term performance for the CoreValve transcatheter aortic valve replacement system from Medtronic, Inc.

From Medtronic 29 Aug 2011

'Electronic nose' smells heart failure

A German team has developed a completely new non-invasive method to identify heart failure. It consists of an "electronic nose" which could make the "smelling" of heart failure possible. The projet was presented at the ESC Congress 2011 today.

29 Aug 2011

Research roundup: The costs of obesity; Patients' post-hospital medicine; Women and heart failure

Association of ICU or Hospital Admission With Unintentional Discontinuation of Medications for Chronic Diseases -- Researchers examined records of older people admitted to a hospital in Ontario, Canada from 1997-2009 who were already taking medicines for chronic health problems. They measured "failure to renew the prescription within 90 days after hospital discharge," and found that patients "prescribed medications for chronic diseases were at risk for potentially unintentional discontinuation after hospital admission.

26 Aug 2011

NeoStem featured on CBS's Eye on New York City

NeoStem, Inc., an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company was featured on CBS's Eye on New York City on Wednesday evening, August 24, 2011.

26 Aug 2011

AHRQ finds significant drop in hospital deaths from heart failure between 2000-2007

The death rate of hospital patients who were admitted primarily for heart failure fell roughly by half between 2000 and 2007 - from 55 deaths to 28 deaths per 1,000 admissions, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

26 Aug 2011

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, announced today that results of the Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) clinical study were published in the European Journal of Heart Failure.

26 Aug 2011

Antidepressant alert – Citalopram associated to heart rhythm disturbances

Antidepressant citalopram (Celexa, Forest Laboratories) should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration (FDA) warns.

25 Aug 2011

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.

25 Aug 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2011.

25 Aug 2011

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Cortex Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent that protects the use of AMPAKINE molecules for the treatment or prevention of respiratory depression.

25 Aug 2011

Heart failure risk rises in people with diastolic dysfunction: Study

New research suggests that a common form of heart trouble called diastolic dysfunction appears to worsen over time and may lead to an increased risk of heart failure. In people with diastolic dysfunction, which often comes with advancing age, the heart's left ventricle fills with blood in an abnormal way and is accompanied by elevated filling pressures.

24 Aug 2011

Trophos awarded US patent covering use of novel cardioprotective compound

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the use of their novel mitochondrial pore modulator, TRO40303, for cytoprotection. The patent provides coverage for the use of Trophos’ TRO40303 to reduce the cardiac reperfusion injury that contributes significantly to the morbidity and mortality seen after a heart attack (myocardial infarction - MI).

23 Aug 2011

Heart Failure News and Research

Further Reading

Ivabradine reduces heart volume among patients with cardiac insufficiency

Chocolate for the heart - benefits revealed

Specific inhibitor of microRNA-100 can stimulate development of new blood vessels

Philips to launch first sleep apnea mobile app at ESC 2011 congress

Chocolate consumption might reduce risk of heart disease

One in three AF patients at high risk of stroke are not being prescribed VKA therapy

MitraClip treatment could benefit heart failure patients who are unresponsive to CRT

Strong link between leisure-time physical activity and AF among men

New clinical data shows positive long-term performance of Medtronic's CoreValve system

'Electronic nose' smells heart failure

Research roundup: The costs of obesity; Patients' post-hospital medicine; Women and heart failure

NeoStem featured on CBS's Eye on New York City

AHRQ finds significant drop in hospital deaths from heart failure between 2000-2007

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

Antidepressant alert – Citalopram associated to heart rhythm disturbances

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Heart failure risk rises in people with diastolic dysfunction: Study

Trophos awarded US patent covering use of novel cardioprotective compound

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News